Designated a national guiding center for complex and severe diseases, PUMCH leads China's national rare disease diagnosis and treatment network. In 2021, it was approved for national medical center development and the public hospital high-quality development pilot. A national key laboratory supports complex and rare disease research.
Founded by the Rockefeller Foundation in 1921 with the ambition to become Asia's finest medical center, PUMCH nurtured generations of physicians, including Zhang Xiaoqian and Lin Qiaozhi. Its teaching tradition joins basic theory, knowledge and skills with rigorous standards. Professors, case records and the library are its celebrated 'three treasures'; medical education and residency training remain central to its national role.
At PUMCH's centenary in 2021, Johns Hopkins Medicine CEO Paul Rothman and China Medical Board chair Wendy O'Neill sent video congratulations. This international exchange builds on the hospital's Rockefeller origins and continuing contribution to medical education and research.
Founded by the Rockefeller Foundation in 1921 with the ambition to become Asia's finest medical center, PUMCH nurtured generations of physicians, including Zhang Xiaoqian and Lin Qiaozhi. Its teaching tradition joins basic theory, knowledge and skills with rigorous standards. Professors, case records and the library are its celebrated 'three treasures'; medical education and residency training remain central to its national role.
The rheumatology service treats conditions including lupus, rheumatoid arthritis and Sjögren’s syndrome, with expertise in complex autoimmune disease.
Read morePancreatic care draws on surgery, gastroenterology, imaging, pathology and oncology to assess complex cases across specialties.
Read moreA dedicated rare-disease inpatient ward opened in February 2024, bringing several specialties together for rare and undiagnosed conditions.
Read moreDongdan and Xidan are two Beijing campuses.
PUMCH